Cripto blockade reduces prostate cancer reactivity to microenvironment and metastatic potential

La Manna, F.; Staender, L.; Gray, P. C.; Zoni, E.; Karkampouna, S.; Thalmann, G. N.; Kruithof-de Julio, M. (15 March 2019). Cripto blockade reduces prostate cancer reactivity to microenvironment and metastatic potential. European Urology Supplements, 18(1), e1156-e1156. Elsevier 10.1016/S1569-9056(19)30833-4

[img] Text
Cripto blockade reduces prostate cancer reactivity to microenvironment and metastatic potential.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (88kB)

Item Type:

Conference or Workshop Item (Abstract)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Urologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Urologie

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology

UniBE Contributor:

La Manna, Federico; Ständer, Lisa; Zoni, Eugenio; Karkampouna, Sofia; Thalmann, George and Kruithof-de Julio, Marianna

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1569-9056

Publisher:

Elsevier

Language:

English

Submitter:

Jeannine Wiemann

Date Deposited:

27 Jan 2020 12:31

Last Modified:

27 Jan 2020 12:31

Publisher DOI:

10.1016/S1569-9056(19)30833-4

BORIS DOI:

10.7892/boris.137868

URI:

https://boris.unibe.ch/id/eprint/137868

Actions (login required)

Edit item Edit item
Provide Feedback